Hay | Department of Medicine | School of Medicine

Annette Hay MD

Position(s)

Division Chair

Professor

Contact Info

ahay@ctg.queensu.ca

613-533-2946

Research Profile

Dr. Annette Hay is a Clinician Scientist. She is a Hematologist within the Department of Medicine, Queen’s University, cross-appointed to the Departments of Oncology and Pediatrics, and a Senior Investigator with the Canadian Cancer Trials Group (CCTG). She became Chair of the Division of Hematology in January 2021.

Commencing at the University of Dundee (Sept 1996 – June 2001, MB ChB received July 2001), Dr. Hay completed her medical and hematology training in Scotland. In 2012 she undertook a 30 month Fellowship with the NCIC Clinical Trials Group (now CCTG), transitioning to a Senior Investigator role in 2014.

Dr. Hay’s clinical practice is focused on hematological malignancies. Clinics are held at the Cancer Centre of Southeastern Ontario.

Dr. Hay’s specific research interests, delivered through collaboration with national and international investigators, include:

Clinical trial design, conduct and analysis: Completion of phase I, II and III trials for patients with lymphoma, leukemia, myeloma and myelodysplasia.
Cell therapy: testing new therapies, and new means of manufacturing them.
Under-represented populations: Enhancing research opportunities and clinical trial uptake including for the elderly, adolescents and young adults with cancer.
Economic analyses: Determining the costs and benefits of healthcare interventions, aiding policy makers.
Data linkage: Piloting means to conduct clinical trials more efficiently, while maintaining patient safety and privacy, though linkage with existing data sources.
Data sharing: Creating the infrastructure for responsible data sharing in Canada to accelerate health care advances.

More information on Dr. Hay's research can be found at the following link.

Dr. Hay’s awards include the John H. Crookston Award from the Canadian Hematology Society (2012), the NCIC Clinical Trials Group Dr. Ralph Meyer Phase III Young Investigator Award (2014), the Queen's University Internal Medicine Sub-specialty Teaching Award (2015), the NIH National Cancer Institute US Director’s Award of Merit (2022) and Queen’s University Department of Medicine Research Achievement Award (2022).

Team

Faculty & Staff